Helper T cells may hold key to precision allergy treatment
US researchers have connected a rare T cell called Th9 with treating allergies, testing in mouse models with asthma.
List view / Grid view
US researchers have connected a rare T cell called Th9 with treating allergies, testing in mouse models with asthma.
US researchers utilise a new approach to immunotherapy, using exhausted T cells that could help overcome treatment resistance in cancers.
US researchers suggest that combing a dual gene-editing approach with antiretroviral drugs can eliminate HIV infections in animal models.
Australian scientists explored a group of bacterial pathogens that share a protein sequence which is recognised by human T cells.
According to US researchers, insights from mouse models of salmonella could lead to better vaccines and immunity.
New findings in mice using artificial sweeteners could result in new therapies to regulate the immune system in those with autoimmune diseases, potentially improving outcomes.
Spreading cancer can halt natural pathway that should recruit killer T cells directly to where it has metastasised, US scientists report.
UW researchers at the Carbone Cancer Center have identified the cells that can cause graft versus host disease, the most common complication of bone marrow transplants.
Discover how the adoption of animal-free media/supplements can improve reproducibility in cell culture and biotherapeutic research.
US discovery opens the way to drugs that can prevent T cell therapies from losing their potency over time.
The PSMA Protein is a new therapeutic hot target. In this article, learn about its growing role in the fight against prostate cancer and beyond.
The researchers say their new discovery could be used to design better vaccines and to gain a deeper insight into autoimmune diseases and allergies.
Results show the number of specialised immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumours.
A new approach using CAR T-cell therapy is suggested by Swedish researchers as an effective treatment for ovarian cancer.
Researchers found that ‘rational vaccinology’ increases potency by changing the structural location of antigens and adjuvants.